Case Details for "Emageon, Inc"

Securities investigation of Emageon related to proposed acquisition

A securities invrestigation has been commenced exploring whether members of the Board of Directors of Emageon, Inc. (Nasdaq:EMAG) may have breached their fiduciary duties in connection with AMICAS, Inc's proposed cash tender offer for all outstanding shares of Emageon at a purchase price of $1.82 per share. Specifically, the investigation is focused on claims that the Board wrongfully failed to maximize value for the Company's stockholders when negotiating and entering into the agreement with AMICAS.

Posted on:03/20/2009
Company: Emageon, Inc
Affected Class: All current stock holders of Emageon, Inc
Scope: Nationwide

Contact Us Regarding This Investigation:

First Name
Last Name
Email Address
Phone Number
State of Residence	Please select Outside of US or Canada Canada Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District Of Columbia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Palau Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virgin Islands Virginia Washington West Virginia Wisconsin Wyoming
Name of Company At Issue
Description / Explanation
Security Code Please enter the code provided in the text box to submit this form.